• NasoClear® Night Formula

NasoClear® Night Formula

Nasal Spray - One Month Supply

SKU: 011

About The Product



NasoClear Extended Relief Night Formula is a natural nasal spray that helps open nasal passages for easy breathing so you can enjoy a restful night without the inconvenience of wearing an apparatus or a nasal strip.

  • No known side effects or rebound effects 
  • No drip, burning, or stinging
  • Non-drowsy
  • Non-habit forming

Directions: Adults and children over 5 years of age (with adult supervision) shake before each use. Take 15 minutes before food or other medicines. Dosage may be repeated up to 4 times in a 24 hr period. Remove cap and safety clip. First time use, prime the pump by depressing several times. Hold with thumb at bottom of bottle and the nozzle between two fingers. Place tip of nozzle just past the nasal passage. Pump once into each nostril. Inhale deeply to spread the medicated solution. Clean tip of nozzle after each use and replace cap. 

* Individual results may vary. 


Active Ingredients:
  • Eucalyptol 3X: helps relieve nasal congestion 
  • Euphorbium 4X: helps open nasal passages
  • Hepar sulph calc 6X: helps relieve allergy symptoms 
  • Pulsatilla prat 3X: helps open nasal passages 
  • Sambucus can 1X: helps open nasal passages
Inactive Ingredients:
  • Benzalkonium Chloride (0.04%)
  • Benzyl Alcohol 
  • Ethyl Alcohol
  • Potassium Chloride
  • Potassium Phosphate
  • Purified water (98%)
  • Sodium Chloride
  • Sodium Phosphate

NasoClear Night Formula ingredients have been diluted out according to the Homeopathic Pharmacopeia of the United States. All ingredients are recognized as an official collection of accepted ingredients by the Federal Food, Drug and Cosmetic Act and are manufactured in FDA approved laboratories. Therefore this water based formula is harmless as it contains no alkaloids. Each ingredient derives from plant, mineral, or protein sources and is present only in harmless microscopic amounts in each dose. 

Dilution Scale: 6X is equal to one part per million.

Claims follow requirement in CPG 400.400 and GLP of Sections 502 & 503 of the FDCA (“The Act”) and Part 201 Title 21 of the CFR to include Principle Display Panel of OTC Drug Labeling under 21 CFR 201.62. Uses and claims are taken from various authorized Materia Medica for references. They have not been reviewed by the Federal Drug and Administration.